Sophie Walsh, Eunhee Choi, Chloe Fang, Keisuke Narita, Maria Cepeda, Brulinda Frangaj, Sofia Kim, Yaniris Mercado, Riley Nesheim-Case, Uriel Alvira Ramirez, Matthew Barrett, Joseph E Schwartz, Daichi Shimbo
{"title":"根据2017年美国心脏病学会/美国心脏协会血压指南,使用边界高压阈值诊断隐匿性高血压的诊断准确性","authors":"Sophie Walsh, Eunhee Choi, Chloe Fang, Keisuke Narita, Maria Cepeda, Brulinda Frangaj, Sofia Kim, Yaniris Mercado, Riley Nesheim-Case, Uriel Alvira Ramirez, Matthew Barrett, Joseph E Schwartz, Daichi Shimbo","doi":"10.1093/ajh/hpaf017","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The 2017 American College of Cardiology (ACC)/American Heart Association (AHA) BP guideline recommends ambulatory BP monitoring (ABPM) for diagnosing masked hypertension among adults not taking antihypertensive medication with borderline office BP (i.e., office systolic BP [SBP] 120 to < 130 mm Hg or diastolic BP [DBP] 75 to < 80 mm Hg).</p><p><strong>Methods: </strong>Using data from the Improving the Detection of Hypertension Study, sensitivity (SN), specificity (SP), positive predictive value (PPV), negative predictive value (NPV), and likelihood ratios for a positive and negative test of having borderline office BP (i.e., office SBP 120 to < 130 mm Hg or DBP 75 to < 80 mm Hg) for diagnosing masked hypertension (i.e., mean awake SBP ≥ 130 mm Hg or mean awake DBP ≥ 80 mm Hg) were determined among 263 participants who had a mean office SBP < 130 mm Hg and mean DBP < 80 mm Hg. Likelihood ratios for a positive test > 10, 5-10, and < 5 were considered strong, moderate, and weak, respectively. Likelihood ratios for a negative test < 0.1, 0.1-0.2, and > 0.2 were considered strong, moderate, and weak, respectively.</p><p><strong>Results: </strong>Among the 263 participants, mean ± SD age was 39.2 ± 12.8 years, 62.4% were female, 38.4% had borderline office BP, and 26.2% had masked hypertension. SN, SP, PPV, and NPV were 0.754, 0.747, 0.515, and 0.895, respectively. The likelihood ratios for a positive and negative test were 2.984 (weak) and 0.330 (weak), respectively.</p><p><strong>Conclusions: </strong>The use of borderline office BP thresholds recommended in the 2017 ACC/AHA BP guideline did not sufficiently rule in or rule out masked hypertension.</p>","PeriodicalId":7578,"journal":{"name":"American Journal of Hypertension","volume":" ","pages":"288-294"},"PeriodicalIF":3.2000,"publicationDate":"2025-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11997242/pdf/","citationCount":"0","resultStr":"{\"title\":\"The Diagnostic Accuracy of Using Borderline High Office Blood Pressure Thresholds to Diagnose Masked Hypertension According to the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline.\",\"authors\":\"Sophie Walsh, Eunhee Choi, Chloe Fang, Keisuke Narita, Maria Cepeda, Brulinda Frangaj, Sofia Kim, Yaniris Mercado, Riley Nesheim-Case, Uriel Alvira Ramirez, Matthew Barrett, Joseph E Schwartz, Daichi Shimbo\",\"doi\":\"10.1093/ajh/hpaf017\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The 2017 American College of Cardiology (ACC)/American Heart Association (AHA) BP guideline recommends ambulatory BP monitoring (ABPM) for diagnosing masked hypertension among adults not taking antihypertensive medication with borderline office BP (i.e., office systolic BP [SBP] 120 to < 130 mm Hg or diastolic BP [DBP] 75 to < 80 mm Hg).</p><p><strong>Methods: </strong>Using data from the Improving the Detection of Hypertension Study, sensitivity (SN), specificity (SP), positive predictive value (PPV), negative predictive value (NPV), and likelihood ratios for a positive and negative test of having borderline office BP (i.e., office SBP 120 to < 130 mm Hg or DBP 75 to < 80 mm Hg) for diagnosing masked hypertension (i.e., mean awake SBP ≥ 130 mm Hg or mean awake DBP ≥ 80 mm Hg) were determined among 263 participants who had a mean office SBP < 130 mm Hg and mean DBP < 80 mm Hg. Likelihood ratios for a positive test > 10, 5-10, and < 5 were considered strong, moderate, and weak, respectively. Likelihood ratios for a negative test < 0.1, 0.1-0.2, and > 0.2 were considered strong, moderate, and weak, respectively.</p><p><strong>Results: </strong>Among the 263 participants, mean ± SD age was 39.2 ± 12.8 years, 62.4% were female, 38.4% had borderline office BP, and 26.2% had masked hypertension. SN, SP, PPV, and NPV were 0.754, 0.747, 0.515, and 0.895, respectively. The likelihood ratios for a positive and negative test were 2.984 (weak) and 0.330 (weak), respectively.</p><p><strong>Conclusions: </strong>The use of borderline office BP thresholds recommended in the 2017 ACC/AHA BP guideline did not sufficiently rule in or rule out masked hypertension.</p>\",\"PeriodicalId\":7578,\"journal\":{\"name\":\"American Journal of Hypertension\",\"volume\":\" \",\"pages\":\"288-294\"},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2025-04-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11997242/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Hypertension\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/ajh/hpaf017\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Hypertension","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ajh/hpaf017","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
The Diagnostic Accuracy of Using Borderline High Office Blood Pressure Thresholds to Diagnose Masked Hypertension According to the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline.
Background: The 2017 American College of Cardiology (ACC)/American Heart Association (AHA) BP guideline recommends ambulatory BP monitoring (ABPM) for diagnosing masked hypertension among adults not taking antihypertensive medication with borderline office BP (i.e., office systolic BP [SBP] 120 to < 130 mm Hg or diastolic BP [DBP] 75 to < 80 mm Hg).
Methods: Using data from the Improving the Detection of Hypertension Study, sensitivity (SN), specificity (SP), positive predictive value (PPV), negative predictive value (NPV), and likelihood ratios for a positive and negative test of having borderline office BP (i.e., office SBP 120 to < 130 mm Hg or DBP 75 to < 80 mm Hg) for diagnosing masked hypertension (i.e., mean awake SBP ≥ 130 mm Hg or mean awake DBP ≥ 80 mm Hg) were determined among 263 participants who had a mean office SBP < 130 mm Hg and mean DBP < 80 mm Hg. Likelihood ratios for a positive test > 10, 5-10, and < 5 were considered strong, moderate, and weak, respectively. Likelihood ratios for a negative test < 0.1, 0.1-0.2, and > 0.2 were considered strong, moderate, and weak, respectively.
Results: Among the 263 participants, mean ± SD age was 39.2 ± 12.8 years, 62.4% were female, 38.4% had borderline office BP, and 26.2% had masked hypertension. SN, SP, PPV, and NPV were 0.754, 0.747, 0.515, and 0.895, respectively. The likelihood ratios for a positive and negative test were 2.984 (weak) and 0.330 (weak), respectively.
Conclusions: The use of borderline office BP thresholds recommended in the 2017 ACC/AHA BP guideline did not sufficiently rule in or rule out masked hypertension.
期刊介绍:
The American Journal of Hypertension is a monthly, peer-reviewed journal that provides a forum for scientific inquiry of the highest standards in the field of hypertension and related cardiovascular disease. The journal publishes high-quality original research and review articles on basic sciences, molecular biology, clinical and experimental hypertension, cardiology, epidemiology, pediatric hypertension, endocrinology, neurophysiology, and nephrology.